Which company won the pivotal 2018 patent battle over CRISPR-Cas9 gene editing technology in Europe, securing rights to the technology in all cell types?

CRISPR-Cas9 gene editing technology has revolutionized scientific research and sparked numerous biotechnology startups. Behind these groundbreaking innovations are companies with carefully crafted brand identities competing in a cutting-edge market. Test your knowledge about one of the most significant scientific brand identity battles in recent history!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

• The Broad Institute (affiliated with MIT and Harvard)
• CRISPR Therapeutics (founded by Emmanuelle Charpentier)
• Editas Medicine (backed by Bill Gates)
• Intellia Therapeutics (co-founded by Jennifer Doudna)

Powered by AIPolls.Net — AI-powered real-time polling platform.